Company Filing History:
Years Active: 2022-2025
Title: The Innovative Contributions of Marc Mansour
Introduction
Marc Mansour is a notable inventor based in Reston, Virginia. He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic peptides. With a total of two patents to his name, his work focuses on innovative solutions for various medical challenges.
Latest Patents
Marc Mansour's latest patents include the development of LAG3 binding peptides. These disclosures provide nucleic acids encoding peptides that bind to LAG3, which can block the interaction of LAG3 with other molecules such as MHC-II, FGL1, and α-synuclein. The therapeutic applications of these peptides are vast, including the inhibition of hyperproliferative disorders like cancer, the progression of synucleinopathies, sepsis, infectious diseases, and enhancing responses to vaccines.
Career Highlights
Marc is currently employed at Leidos, Inc., where he continues to push the boundaries of medical research and innovation. His work is characterized by a commitment to developing solutions that address critical health issues.
Collaborations
Throughout his career, Marc has collaborated with talented individuals such as Gabriel M Gutierrez and Vinayaka Kotraiah. These partnerships have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Marc Mansour's innovative work in the field of biotechnology exemplifies the impact of dedicated inventors on healthcare solutions. His contributions through LAG3 binding peptides highlight the potential for new therapeutic approaches to complex medical conditions.